サマリー

The global gynecology devices market reached a value of US$ 10.76 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 8.2% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.

Gynecology devices are used to treat conditions associated with the female reproductive system. These devices assist in performing colposcopy, loop tubal ligation, endometrial biopsy, ovarian cystectomy, electrical excision procedure (LEEP), intrauterine device (IUD) insertion, and dilation and curettage (D&C). Some of the widely used gynecology devices are forceps and clamps for caesarian delivery, cervical dilators for stretching the cervical muscles, and punch forceps for premalignant lesions of the cervix. Recent advances in lasers have escalated the demand for gynecology devices across the globe to treat cysts, endometriosis, genital warts, fibroid tumors, abnormal uterine bleeding, ectopic pregnancy, and urinary incontinence.

Gynecology Devices Market Trends:
A significant rise in the number of women with gynecological conditions, such as cervical cancer, vaginal melanoma, extended bleeding, irregular menstrual cycles, and polycystic ovary syndrome, represents one of the primary factors fueling the market growth. Moreover, growing awareness about the benefits of regular check-ups is influencing the market positively. The emerging trend of minimally invasive (MI) procedures and increasing utilization of imaging devices like three-dimensional (3D) endoscopes is also contributing to the market growth. Apart from this, several manufacturers are investing in research and development (R&D) activities to develop efficient devices that can provide accurate and quick diagnoses and minimize operating time. This, in confluence with the rising need for durable and easy autoclavable surgical instruments, is bolstering the market growth. Furthermore, health authorities of numerous countries are focusing on increasing the number of hospitals for gynecology and improving the services in existing ones. This is anticipated to drive the market in the coming years.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global gynecology devices market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product and end use.

Breakup by Product:

Surgical Devices
Gynecological Endoscopy Devices
Hysteroscope
Colposcope
Resectoscope
Laparoscope
Endoscopic Imaging Systems
Endometrial Ablation Devices
Hydrothermal Ablation Devices
Radiofrequency Ablation Devices
Balloon Ablation Devices
Others
Fluid Management Systems
Female Sterilization/Contraceptive Devices
Permanent Birth Control
Intra Uterine Devices (IUD)
Intravaginal Rings
Subdermal Contraceptive Implants
Hand Instruments
Vaginal Speculum
Tenaculum
Curettes
Trocars
Biopsy Forceps
Others
Others

Breakup by End Use:

Hospitals and Clinics
Diagnostic Centers
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, CooperSurgical Inc., Fresenius Medical Care AG & Co. KGAA, General Electric Company, Hologic Inc., Johnson & Johnson, Karl Storz SE & Co. KG, Medtronic plc, Olympus Corporation, Richard Wolf GmbH, Siemens AG and Stryker Corporation. Key Questions Answered in This Report:
How has the global gynecology devices market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global gynecology devices market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the end use?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global gynecology devices market and who are the key players?
What is the degree of competition in the industry?

ページTOPに戻る

目次

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Gynecology Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Surgical Devices
6.1.1 Market Trends
6.1.2 Market Breakup by Type
6.1.2.1 Gynecological Endoscopy Devices
6.1.2.1.1 Market Trends
6.1.2.1.2 Major Types
6.1.2.1.2.1 Hysteroscope
6.1.2.1.2.2 Colposcope
6.1.2.1.2.3 Resectoscope
6.1.2.1.2.4 Laparoscope
6.1.2.1.2.5 Endoscopic Imaging Systems
6.1.2.1.3 Market Forecast
6.1.2.2 Endometrial Ablation Devices
6.1.2.2.1 Market Trends
6.1.2.2.2 Major Types
6.1.2.2.2.1 Hydrothermal Ablation Devices
6.1.2.2.2.2 Radiofrequency Ablation Devices
6.1.2.2.2.3 Balloon Ablation Devices
6.1.2.2.2.4 Others
6.1.2.2.3 Market Forecast
6.1.2.3 Fluid Management Systems
6.1.2.3.1 Market Trends
6.1.2.3.2 Market Forecast
6.1.2.4 Female Sterilization/Contraceptive Devices
6.1.2.4.1 Market Trends
6.1.2.4.2 Major Types
6.1.2.4.2.1 Permanent Birth Control
6.1.2.4.2.2 Intra Uterine Devices (IUD)
6.1.2.4.2.3 Intravaginal Rings
6.1.2.4.2.4 Subdermal Contraceptive Implants
6.1.2.4.3 Market Forecast
6.1.3 Market Forecast
6.2 Hand Instruments
6.2.1 Market Trends
6.2.2 Major Types
6.2.2.1 Vaginal Speculum
6.2.2.2 Tenaculum
6.2.2.3 Curettes
6.2.2.4 Trocars
6.2.2.5 Biopsy Forceps
6.2.2.6 Others
6.2.3 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by End Use
7.1 Hospitals and Clinics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Diagnostic Centers
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Boston Scientific Corporation
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 CooperSurgical Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.3 Fresenius Medical Care AG & Co. KGAA
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.4 General Electric Company
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.5 Hologic Inc.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
13.3.6 Johnson & Johnson
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.7 Karl Storz SE & Co. KG
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 SWOT Analysis
13.3.8 Medtronic plc
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Olympus Corporation
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Richard Wolf GmbH
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 SWOT Analysis
13.3.11 Siemens AG
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
13.3.11.4 SWOT Analysis
13.3.13 Stryker Corporation
13.3.13.1 Company Overview
13.3.13.2 Product Portfolio
13.3.13.3 Financials
13.3.13.4 SWOT Analysis